Brief: Gimv Leads A Eur 72 Mln Series A Financing Round Of Complement Therapeutics
17/04/2023 06:33
April 17 (Reuters) - Gimv NV GIMV.BR :
* GIMV LEADS A 72 MILLION EUR SERIES A FINANCING ROUND OF
COMPLEMENT THERAPEUTICS TO FINANCE FURTHER DEVELOPMENT OF
THERAPIES FOR EYE DISEASES
* COMPLEMENT THERAPEUTICS ANNOUNCES CLOSING OF A 72 MILLION
EUR
SERIES A FINANCING ROUND LED BY GIMV
* FINANCING ROUND WILL ALLOW COMPLEMENT THERAPEUTICS TO
EVALUATE
ITS PIPELINE ASSETS FOR NON-OCULAR INDICATIONS
* FINANCING ROUND WILL ALLOW FURTHER DEVELOP NOVEL
COMPLEMENT
PRECISION MEDICINE (CPM) PLATFORM
Source: bit.ly/3KzCKVK
Further company coverage: GIMV.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))